相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A systematic scoping review on natural killer cell function in colorectal cancer
Fiona S. W. Reid et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Chemokine networks modulating natural killer cell trafficking to solid tumors
Xue Yao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Effects of interleukin-2 in immunostimulation and immunosuppression
Jonathan G. Pol et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Toll-like receptor 2 activation induces C-C chemokine receptor 2-dependent natural killer cell recruitment to the peritoneum
Ian D. Haidl et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
Weiqiang Zhou et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma
Tatiana Pazina et al.
CANCER IMMUNOLOGY RESEARCH (2019)
NK Cells in the Treatment of Hematological Malignancies
Ana P. Gonzalez-Rodriguez et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer
Yurie Yamamoto et al.
ANTICANCER RESEARCH (2019)
Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia
M. Vela et al.
CANCER LETTERS (2018)
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
Lorenzo Mortara et al.
FRONTIERS IN IMMUNOLOGY (2018)
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Michael M. Boyiadzis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
NK cell-based immunotherapy for cancer
Fang Fang et al.
SEMINARS IN IMMUNOLOGY (2017)
Developmental and Functional Control of Natural Killer Cells by Cytokines
Yang Wu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
Veronika Kremer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation
Hsin-Kai Liao et al.
CELL (2017)
Tethering IL2 to Its Receptor IL2Rβ Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells
Youssef Jounaidi et al.
CANCER RESEARCH (2017)
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma
Nina Shah et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
Caroline Jochems et al.
ONCOTARGET (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
Naoyuki Sakamoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer
Yun-Peng Peng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
Andreas Lundqvist et al.
JOURNAL OF CANCER (2011)
Differential Regulation of Chemokines by IL-17 in Colonic Epithelial Cells
Jimmy W. Lee et al.
JOURNAL OF IMMUNOLOGY (2008)
Turnover and proliferation of NK cells in steady state and lymphopenic conditions
AM Jamieson et al.
JOURNAL OF IMMUNOLOGY (2004)